ImageneBio (IMA) Cash & Equivalents (2020 - 2024)
Historic Cash & Equivalents for ImageneBio (IMA) over the last 5 years, with Q3 2024 value amounting to $45.2 million.
- ImageneBio's Cash & Equivalents fell 6273.82% to $45.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was $45.2 million, marking a year-over-year decrease of 6273.82%. This contributed to the annual value of $119.9 million for FY2023, which is 10009.35% up from last year.
- According to the latest figures from Q3 2024, ImageneBio's Cash & Equivalents is $45.2 million, which was down 6273.82% from $44.3 million recorded in Q2 2024.
- Over the past 5 years, ImageneBio's Cash & Equivalents peaked at $281.0 million during Q1 2021, and registered a low of $29.3 million during Q1 2023.
- For the 5-year period, ImageneBio's Cash & Equivalents averaged around $109.6 million, with its median value being $67.1 million (2022).
- As far as peak fluctuations go, ImageneBio's Cash & Equivalents skyrocketed by 34020.59% in 2021, and later crashed by 8331.84% in 2022.
- ImageneBio's Cash & Equivalents (Quarter) stood at $162.5 million in 2020, then surged by 42.91% to $232.2 million in 2021, then crashed by 74.2% to $59.9 million in 2022, then soared by 100.09% to $119.9 million in 2023, then crashed by 62.31% to $45.2 million in 2024.
- Its Cash & Equivalents stands at $45.2 million for Q3 2024, versus $44.3 million for Q2 2024 and $52.9 million for Q1 2024.